Table 5.
Simple linear regression analysis of mental component summary scores in patients with moderate and advanced chronic kidney disease n = 202
Variable | Coefficient | Standard error | t | 95% confidence interval | P value |
---|---|---|---|---|---|
Age | −0.01 | 0.05 | −0.01 | − 0.93–0.09 | 0.995 |
Educational level | 1.42 | 1.51 | 0.94 | − 1.56–4.41 | 0.348 |
Employment status | −0.61 | 1.51 | −0.40 | −3.60–2.38 | 0.690 |
Low income | −6.08 | 1.91 | −3.18 | −9.84–−2.30 | 0.002 |
Marital status | 0.66 | 1.62 | 0.41 | −2.54–3.86 | 0.685 |
Hypertension | −1.70 | 1.64 | −1.03 | −4.93–1.54 | 0.303 |
Hemoglobin | 1.15 | 0.29 | 3.95 | 0.57–1.72 | < 0.001 |
MCV | 0.21 | 0.10 | 2.10 | 0.01–0.40 | 0.037 |
MCH | 0.32 | 0.24 | 1.35 | −0.15–0.80 | 0.178 |
Uraemia | −3.78 | 1.55 | −2.45 | −6.83–−0.73 | 0.015 |
CKD stage 5 | −4.36 | 1.65 | −2.64 | −7.62–1.10 | 0.009 |
ESA use | 0.34 | 2.60 | .0.13 | −4.76–5.48 | 0.895 |
IV Iron | 14.12 | 5.35 | 2.64 | 3.56–24.69 | 0.009 |
MCV mean corpuscular volume, MCH mean corpuscular haemoglobin, CKD 5 chronic kidney disease with GFR < 15 ml/min/1.73m2, ESA erythropoietin stimulating agent, IV intravenous, CI confidence interval, uraemia serum urea > 20 mmol/L